CA2449468A1 - Cardiac stimulating apparatus having a blood clot filter and atrial pacer - Google Patents
Cardiac stimulating apparatus having a blood clot filter and atrial pacer Download PDFInfo
- Publication number
- CA2449468A1 CA2449468A1 CA 2449468 CA2449468A CA2449468A1 CA 2449468 A1 CA2449468 A1 CA 2449468A1 CA 2449468 CA2449468 CA 2449468 CA 2449468 A CA2449468 A CA 2449468A CA 2449468 A1 CA2449468 A1 CA 2449468A1
- Authority
- CA
- Canada
- Prior art keywords
- stimulating apparatus
- atrial
- cardiac stimulating
- atrial appendage
- pacer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
- A61N1/39622—Pacing therapy
Abstract
An apparatus (10) is provided for reducing the formation and migration of blood clots from an atrial appendage, such as the left atrial appendage, to the blood vessel system of a patient. The apparatus comprises an atrial pacer (12) to treat non-rheumatic atrial fibrillation (NRAF) of an atrial appendage so that the formation blood clots within the atrial appendage is decreased or eliminated. In addition, the apparatus includes a blood clot filter (28) supported by the atrial pacer proximate the atrial appendage and the atrium to reduce the migration of blood clots from the atrial appendage into the blood vessel system of a patient.
Description
Cardiac Stimulating Apparatus Having a Blood Clot Filter and Atrial Pacer Field Of The Invention The present invention relates generally to a device that deters migration of emboli from an atrial appendage into the vascular system of a patient, and more particularly to a device that includes a filter to deter such migration and a pacer to deter the formation of emboli such as blood clots within the atrial appendage.
l0 Background Of The Invention Non-rheumatic atrial fibrillation (NRAF) is associated with thromboembolic complications such as strokes. For example, when a thrombus or embolus occludes a vessel supplying blood to the brain, a stroke may result causing temporary or lasting paralysis of a part of the body or, in severe cases, death. Blockage of other blood vessels can occur as well causing attendant health concerns, including heart attack or gangrene. Presently, a five percent risk of stroke per year in a largely aging population causes NRAF to be a significant health concern. Given the potentially irreversible and destructive nature of such blood vessel occlusion, safe and effective methods are needed to eliminate embolic material like blood clots from the vascular system, some of which may be formed within an atrial appendage of the heart.
The left atrial appendage forms a small protrusion which is attached to the lateral wall of the left atrium between the mitral valve and the root of the left pulmonary vein and normally contracts along with the left atrium. Atrial fibrillation is a cardiac condition wherein the atria beat faster than the ventricles, causing the ventricles to contract irregularly and consequently eject less blood into the vascular system. A major problem associated with atrial fibrillation is pooling of blood in the left atrial appendage.
During NRAF the left atrial appendage may not fully contract, leaving stagnant blood within the left atrial appendage. In turn, the stagnant blood may create a condition favorable to the formation of blood clots within the left atrial appendage. Such clots may travel from the left atrial appendage into the left atrium and into the vascular system, thereby increasing the danger of stroke or cardiac blockage.
Traditional treatments to mitigate the risks posed by blood clots include the use of anticoagulants to dissolve the clots. For example, recently published results from stroke prevention trials suggest that prophylaxis with anticoagulation is beneficial to patients with non-rheumatic, non-valvular atrial fibrillation. Current therapeutic interventions include anticoagulation with coumedin. In addition, therapeutic interventions include the use of atrial rate regulating medications. However, both of these treatment approaches pose potential complications such as internal bleeding, as well as other negative side effects caused by the rate regulating therapeutic agents.
In addition to pharmacological treatments, complex radical surgical methods are available to treat atrial fibrillation. Such treatments include, for example, atrial incisions or removal of the left atrial appendage, which have been attempted in a limited, experimental way. Such approaches are highly invasive and pose a risk of mortality to the patient. Thus, a pressing need exists for means by which the formation of blood clots the left atrial appendage is substantially deterred while preventing the migration of any blood clots which may form from entering the vascular system.
U.S. Patent 6,152,144 to Lesh et al., for example, discloses a device and method for obliterating or occluding a body cavity or passageway.
Specifically, the patent to Lesh is directed to a device and method for obliterating or occluding the left atrial appendage of a patient's heart. In one embodiment, L.esh et al. disclose a frame structure having a barner or mesh material disposed over it to act as a barrier to the passage of embolic material.
However, Lesh et al. do not disclose a device or method suited to treat atrial fibrillation, or other arrhythmias of the heart, to thereby prevent the formation of clots in the left atrial appendage. As such, the barrier embodiment of Lesh et al. permits ongoing formation of clots within the left atrial appendage, which may eventually occlude the barrier material to prevent fluid flow as well as embolic material flow through the occluded barrier. Such a situation may present a health concern as the left atrial appendage contracts and the blood enclosed therein is unable to exit the left atrial appendage. Such contraction may result in an increased pressure in the left atrial appendage capable of weakening the wall of the left atrial appendage. Additionally, as the barrier embodiment of Lesh et al. does not prevent the formation of clots, it is possible that the volume of the left atrial appendage may eventually be filled with coagulated blood. Thus, filtering alone poses possible added health concerns.
Regarding the treatment of atrial fibrillation, it is known to use a pacemaker, for example, as disclosed in U.S. Patent 6,178,351 Bl to Mower.
Mower discloses a pacemaker that is capable of pacing the atria from multiple sites, but does not address prevention of migration of embolic material within the vascular system. Moreover, neither Mower nor Lesh suggests combining a pacer with an embolic barner for use in the heart.
Accordingly, there is a need for an apparatus for mitigating the risks associated with emboli originating in the left atrial appendage and also for reducing the tendency of such emboli, such as blood clots, to form therein.
Summar~r of the Invention An apparatus is provided for deterring the formation and migration of blood clots from an atrial appendage, such as a left or right atrial appendage, into the blood vessel system, i.e. vascular system, of a patient. In particular, an apparatus of the present invention comprises an atrial pacer to treat non-rheumatic atrial fibrillation (NRAF) or other arrhythmias of an atrial appendage so that the formation of blood clots within such atrial appendage is decreased or eliminated. In addition, the apparatus provides a blood clot filter to deter the migration of blood clots from an atrial appendage into the blood vessel system of a patient.
More specifically, the apparatus comprises a filter for reducing the transport of emboli from an atrial appendage to an atrium of the heart. The filter is formed to provide a structure suitable for separating blood clots from the blood and for reducing passage of blood clots from the atrial appendage into the atrium and general circulation. In accordance with one aspect of the invention, the filter can take the form of a plurality of spokes extending outwardly from the atrial pacer. In another aspect, the filter can take the form of a mesh having pores sized to deter the passage of blood clots.
In accordance with another aspect of the invention, the apparatus comprises an atrial pacer which supports the filter between an atrial appendage and the atrium. The atrial pacer is adapted to be in contact with a wall of the atrial appendage so the atrial pacer may detect and reduce atrial fibrillation in the atrial appendage. The pacer also includes a sensor which may form an integral part of the atrial pacer for sensing fibrillation in the atrial appendage. In an alternative arrangement, the sensor may be adapted to be positioned externally to the heart. In this external arrangement, a lead wire may be provided between the sensor and the atrial wall, to provide sensing contact between the sensor and the atrial wall. The atrial pacer also comprises a stimulator for stimulating the atrial appendage. The simulator may take the form of an electrode for making electrical contact with the wall of the atrial appendage to apply stimulating signals to the atrial appendage. The stimulator may be activated in response to a signal from the sensor indicating the presence of NRAF, or other arrythmias, in the atrial appendage.
A control unit adapted to be positioned externally to the heart may optionally be provided for controlling the atrial pacer. The control unit may communicate with the sensor and/or the stimulator using a lead wire or wireless technology. In addition, the sensor may be disposed within the control unit.
For example, in the arrangement where the sensor is positioned externally to the heart, the sensor may be incorporated within the control unit.
Brief Description Of The Drawings The foregoing summary and the following detailed description of the preferred embodiments of the present invention will be best understood when read in conjunction with the appended drawings, in which:
Figure 1 is a schematic perspective view showing an exemplary device of the present invention having a mesh filter;
Figure 2 is a schematic perspective view showing an exemplary device of the present invention having a filter which includes a plurality of spokes;
Figure 3 is a schematic view of the exemplary device shown in Figure 1 disposed within a left atrial appendage;
Figure 4 is a schematic view of the exemplary device shown in Figure 2 disposed within a left atrial appendage;
Figure 5 is a schematic block diagram of a first exemplary configuration of an atrial pacer of the present invention having a control unit which includes a sensor and lead wire for detecting a selected condition of the heart;
Figure 6 is a block diagram of a second exemplary configuration of an atrial pacer of the present invention having a control unit for communication with stimulator and sensor;
Figure 7 is a block diagram of a rechargeable configuration of an atrial pacer of the present invention;
l0 Background Of The Invention Non-rheumatic atrial fibrillation (NRAF) is associated with thromboembolic complications such as strokes. For example, when a thrombus or embolus occludes a vessel supplying blood to the brain, a stroke may result causing temporary or lasting paralysis of a part of the body or, in severe cases, death. Blockage of other blood vessels can occur as well causing attendant health concerns, including heart attack or gangrene. Presently, a five percent risk of stroke per year in a largely aging population causes NRAF to be a significant health concern. Given the potentially irreversible and destructive nature of such blood vessel occlusion, safe and effective methods are needed to eliminate embolic material like blood clots from the vascular system, some of which may be formed within an atrial appendage of the heart.
The left atrial appendage forms a small protrusion which is attached to the lateral wall of the left atrium between the mitral valve and the root of the left pulmonary vein and normally contracts along with the left atrium. Atrial fibrillation is a cardiac condition wherein the atria beat faster than the ventricles, causing the ventricles to contract irregularly and consequently eject less blood into the vascular system. A major problem associated with atrial fibrillation is pooling of blood in the left atrial appendage.
During NRAF the left atrial appendage may not fully contract, leaving stagnant blood within the left atrial appendage. In turn, the stagnant blood may create a condition favorable to the formation of blood clots within the left atrial appendage. Such clots may travel from the left atrial appendage into the left atrium and into the vascular system, thereby increasing the danger of stroke or cardiac blockage.
Traditional treatments to mitigate the risks posed by blood clots include the use of anticoagulants to dissolve the clots. For example, recently published results from stroke prevention trials suggest that prophylaxis with anticoagulation is beneficial to patients with non-rheumatic, non-valvular atrial fibrillation. Current therapeutic interventions include anticoagulation with coumedin. In addition, therapeutic interventions include the use of atrial rate regulating medications. However, both of these treatment approaches pose potential complications such as internal bleeding, as well as other negative side effects caused by the rate regulating therapeutic agents.
In addition to pharmacological treatments, complex radical surgical methods are available to treat atrial fibrillation. Such treatments include, for example, atrial incisions or removal of the left atrial appendage, which have been attempted in a limited, experimental way. Such approaches are highly invasive and pose a risk of mortality to the patient. Thus, a pressing need exists for means by which the formation of blood clots the left atrial appendage is substantially deterred while preventing the migration of any blood clots which may form from entering the vascular system.
U.S. Patent 6,152,144 to Lesh et al., for example, discloses a device and method for obliterating or occluding a body cavity or passageway.
Specifically, the patent to Lesh is directed to a device and method for obliterating or occluding the left atrial appendage of a patient's heart. In one embodiment, L.esh et al. disclose a frame structure having a barner or mesh material disposed over it to act as a barrier to the passage of embolic material.
However, Lesh et al. do not disclose a device or method suited to treat atrial fibrillation, or other arrhythmias of the heart, to thereby prevent the formation of clots in the left atrial appendage. As such, the barrier embodiment of Lesh et al. permits ongoing formation of clots within the left atrial appendage, which may eventually occlude the barrier material to prevent fluid flow as well as embolic material flow through the occluded barrier. Such a situation may present a health concern as the left atrial appendage contracts and the blood enclosed therein is unable to exit the left atrial appendage. Such contraction may result in an increased pressure in the left atrial appendage capable of weakening the wall of the left atrial appendage. Additionally, as the barrier embodiment of Lesh et al. does not prevent the formation of clots, it is possible that the volume of the left atrial appendage may eventually be filled with coagulated blood. Thus, filtering alone poses possible added health concerns.
Regarding the treatment of atrial fibrillation, it is known to use a pacemaker, for example, as disclosed in U.S. Patent 6,178,351 Bl to Mower.
Mower discloses a pacemaker that is capable of pacing the atria from multiple sites, but does not address prevention of migration of embolic material within the vascular system. Moreover, neither Mower nor Lesh suggests combining a pacer with an embolic barner for use in the heart.
Accordingly, there is a need for an apparatus for mitigating the risks associated with emboli originating in the left atrial appendage and also for reducing the tendency of such emboli, such as blood clots, to form therein.
Summar~r of the Invention An apparatus is provided for deterring the formation and migration of blood clots from an atrial appendage, such as a left or right atrial appendage, into the blood vessel system, i.e. vascular system, of a patient. In particular, an apparatus of the present invention comprises an atrial pacer to treat non-rheumatic atrial fibrillation (NRAF) or other arrhythmias of an atrial appendage so that the formation of blood clots within such atrial appendage is decreased or eliminated. In addition, the apparatus provides a blood clot filter to deter the migration of blood clots from an atrial appendage into the blood vessel system of a patient.
More specifically, the apparatus comprises a filter for reducing the transport of emboli from an atrial appendage to an atrium of the heart. The filter is formed to provide a structure suitable for separating blood clots from the blood and for reducing passage of blood clots from the atrial appendage into the atrium and general circulation. In accordance with one aspect of the invention, the filter can take the form of a plurality of spokes extending outwardly from the atrial pacer. In another aspect, the filter can take the form of a mesh having pores sized to deter the passage of blood clots.
In accordance with another aspect of the invention, the apparatus comprises an atrial pacer which supports the filter between an atrial appendage and the atrium. The atrial pacer is adapted to be in contact with a wall of the atrial appendage so the atrial pacer may detect and reduce atrial fibrillation in the atrial appendage. The pacer also includes a sensor which may form an integral part of the atrial pacer for sensing fibrillation in the atrial appendage. In an alternative arrangement, the sensor may be adapted to be positioned externally to the heart. In this external arrangement, a lead wire may be provided between the sensor and the atrial wall, to provide sensing contact between the sensor and the atrial wall. The atrial pacer also comprises a stimulator for stimulating the atrial appendage. The simulator may take the form of an electrode for making electrical contact with the wall of the atrial appendage to apply stimulating signals to the atrial appendage. The stimulator may be activated in response to a signal from the sensor indicating the presence of NRAF, or other arrythmias, in the atrial appendage.
A control unit adapted to be positioned externally to the heart may optionally be provided for controlling the atrial pacer. The control unit may communicate with the sensor and/or the stimulator using a lead wire or wireless technology. In addition, the sensor may be disposed within the control unit.
For example, in the arrangement where the sensor is positioned externally to the heart, the sensor may be incorporated within the control unit.
Brief Description Of The Drawings The foregoing summary and the following detailed description of the preferred embodiments of the present invention will be best understood when read in conjunction with the appended drawings, in which:
Figure 1 is a schematic perspective view showing an exemplary device of the present invention having a mesh filter;
Figure 2 is a schematic perspective view showing an exemplary device of the present invention having a filter which includes a plurality of spokes;
Figure 3 is a schematic view of the exemplary device shown in Figure 1 disposed within a left atrial appendage;
Figure 4 is a schematic view of the exemplary device shown in Figure 2 disposed within a left atrial appendage;
Figure 5 is a schematic block diagram of a first exemplary configuration of an atrial pacer of the present invention having a control unit which includes a sensor and lead wire for detecting a selected condition of the heart;
Figure 6 is a block diagram of a second exemplary configuration of an atrial pacer of the present invention having a control unit for communication with stimulator and sensor;
Figure 7 is a block diagram of a rechargeable configuration of an atrial pacer of the present invention;
Figure 8 is a schematic view of the exemplary device shown in Figure 1 with the filter collapsed against the body of the device; and Figure 9 is a schematic view of the exemplary device shown in Figure 2 with the spokes collapsed against the body of the device.
Detailed Description Of The Invention A cardiac stimulating apparatus 10, 100 is provided for substantially reducing the formation of blood clots in an atrial appendage of a heart, such as the left atrial appendage 210, and reducing the migration of such clots into the blood vessel system of a patient. The apparatus 10, 100 comprises a filtration device 28, 124 to reduce migration of embolic material, such as blood clots or the like. In addition, the apparatus 10, 100 includes an atrial pacer 12, 112 to treat arrythmias, such as non-rheumatic atrial fibrillation (NRAF), of the left atrial appendage 210 to deter the formation blood clots within the left atrial appendage 210. Figures 1-4 depict the general structure of a cardiac stimulating apparatus of the present invention, illustrating the cooperation between the atrial pacer 12, 112 and the filtration device, such as filter 28 or spokes 124.
Turning now to Figs. 1 and 3, an embodiment of the present invention is shown in which a cardiac stimulating apparatus 10 comprises an atrial pacer 12 having an elongated generally tubular body 14 having first and second opposing ends 18, 30. The first end 18 of the atrial pacer 12 is adapted to contact the wall of the left atrial appendage 210 to support the cardiac stimulating apparatus within the left atrial appendage 210. The first end 18 may include a sensing device 22 optionally disposed therein to detect NRAF or other arrhythmias in the left atrial appendage 210. In such a configuration, the sensing device 22 is adapted to be in sensing contact with the wall of the left atrial appendage 210.
The first end 18 of the atrial pacer 12 also includes a stimulating device 23 for stimulating the left atrial appendage 210 in response to detection of NRAF by a detector, such as sensing device 22. The stimulating device 23 includes an electrode adapted to be in electrical contact with the wall of the atrial appendage 210 for applying stimulating signals to the atrial appendage 210. By application of an appropriate stimulating signal, NRAF can be reduced or eliminated thereby reducing the tendency of blood within the left atrial appendage 210 to form blood clots. The sensing device 22 and stimulating device 23 may comprise components known for use in atrial pacers.
Extending outwardly from the elongated generally tubular body 14, a filtration device is provided to deter the migration of blood clots from the left atrial appendage 210 into the left atrium 200 of the heart. As shown in Fig.
l, an embodiment of the filtration device may take the form of a mesh-like or sieve-like filter 28. The filter 28 may have a generally conical shape as shown, for example, with the narrower end of the conical filter 28 attached to the atrial pacer 12 proximate to the first end 18 of the atrial pacer 12. Alternatively, the filter 28 may be attached to the atrial pacer 12 at any point along the elongated body 14. The filter 28 may have any shape suited to substantially fill the opening defined by the intersection of the left atrial appendage 210 and the left atrium 200, such as a portion of a sphere, flat sheet, or other shape.
The mesh-like material of the filter 28 may be formed from a metal, such as a stainless-steel, for example. Alternatively, the filter 28 may be formed from a polymeric material, such as a Nylon or Dacron mesh. Other suitable materials such as PTFE or polyamides may also be used. In particular, it is preferable that the filter 28 be formed of a resilient material capable of being collapsed about the body 14 of the atrial pacer 12, as shown in Fig. 8, to facilitate introduction of the cardiac stimulating device 10 into a patient, for example, via a catheter.
The resilient material is chosen such that upon removal of the cardiac stimulating device 10 from the catheter, the filter 28 expands to a desired shape and size to permit the opening of the left atrial appendage 210 to be substantially sealed.
Regardless of the material from which the filter 28 is formed, the filter 28 is formed to provide pores having a transverse dimensions of about 1 mm or other size sufficiently small to prevent the passage of blood clots or other thromboembolic material of like or greater size. In particular, it may be desirable for the pore size to have a transverse dimension up to about 0.1 mm.
The wider end of the filter 28 includes a rim portion 20 which defines the base of the filter 28. The rim portion 20 is sized to circumscribe the opening between the left atrial appendage 210 and left atrium 200, so that emplacement the cardiac stimulating device 10 in the left atrial appendage 210 generally positions the rim portion 20 near the opening left atrial appendage 210 so as to form and maintain a seal therewith. To effect and maintain such a seal, the rim portion 20 may be formed of or covered by a soft polymer material. The rim portion 20 may have a transverse dimension of about 2 to 40 mm, preferably about 25 to 35 mm. The transverse dimension of the rim portion 20 should be selected with regard to the size of the left atrial appendage opening, which may vary among patients, especially those patients having heart disease related conditions.
The rim portion 20 may also include a plurality of holes through which sutures may be placed to anchor the rim portion 20 proximate to the opening of the left atrial appendage 210. Alternatively or additionally, the rim portion may have a spring-like action which causes the rim portion 20 to expand generally radially outward from the longitudinal axis of the atrial pacer 12, so that the rim portion 20 applies pressure against a region proximate the opening of the left atrial appendage 210 to form a seal proximate the opening of the left atrial appendage 210. For example, the rim portion 20 may be formed of a shape memory metal, such as NiTi, having a memorized shape larger than that of the opening of the left atrial appendage 210 to supply the radially outward pressure on the opening. The filter 28 is attached to the atrial pacer 12 at such a location so as to permit the rim portion 20 to substantially form a seal within the left atrial appendage opening and to permit the first end 18 of the atrial pacer 12 to contact the wall of the atrial appendage 210.
Referring now to Figs. 2 and 4, an alternative embodiment of the cardiac stimulating apparatus 100 is shown where the filtration device comprises a plurality of spokes 124 extending generally radially outwardly from the atrial pacer 112, to deter the migration of blood clots from the left atrial appendage 210 of the heart to the left atrium 200 of the heart. The atrial pacer 112 of the alternative embodiment comprises an elongated generally tubular body 114 having first and second ends 118, 130, a stimulating device 123, and an optional sensing device 122 similar to like components 23 and 22 described above with regard to the previous embodiment.
The spokes 124 each comprise a first end 125 attached to the elongated body 114 of the atrial pacer 112 and a second end 127 of the spokes 124 for engaging a region of the heart in the vicinity of the left atrial appendage 210.
The second end 127 of the spokes 124 may terminate in a hook-like tine 126 formed to anchor the spokes 124 and retain the atrial pacer 112 within the left atrial appendage 210. In addition, all or some of the second ends 127 of the spokes 124 may include a hole suitable for placing a suture therethrough for attachment to the left atrial appendage 210. The number of spokes 124 employed should be sufficiently numerous to create interstices between the spokes 124 sufficiently small to deter the passage of embolic material through the interstices.
The first ends 125 of the plurality a spokes 124 may be attached to the body 114 of the atrial pacer 112 at a common distance from the first end 118 of the atrial pacer 112. Alternatively, the first ends 125 of the plurality of spokes 124 may be attached to the body 114 of the atrial pacer 112 at varying distances from the first end 118 of the atrial pacer 112. Providing spokes 124 at a variety of distances from the first end 118 of the atrial pacer 112 may be useful to create a tortuous path to deter the flow of embolic material. For example, a first set of spokes 124 may have first ends 125 adjoining the atrial pacer 112 at a common distance from the first end 118 around the circumference of the atrial pacer 112.
A second set of spokes may have first ends adjoining the atrial pacer 112 at a further distance from the first end 118 of the atrial pacer 112 than the first set of spokes 124. In addition, the second set of spokes may be oriented circumferentially to overlap with the interstices formed among the first set of spokes 124, as viewed from the first end 118 of the atrial pacer 112.
Likewise, additional set of spokes 124 may be included to effect additional blockage of embolic material flow. Moreover, some or all of the spokes 124 may extend outwardly from the atrial pacer 112 along non-radial directions, to enhance blockage of embolic material.
The spokes 124 may be formed of any suitable material such as a metal or polymeric material like those described above with regard to the mesh-like filter 28. It is also desirable that the spokes 124 be sufficiently pliable to permit the spokes 124 to be disposed along the body 114 of the atrial pacer 112, as shown in Fig. 9, while the cardiac stimulating device 100 is placed into a patient via a catheter.
In addition, it is desirable that the spokes 124 be sufficiently resilient so that they expand away from the body 114 of the atrial pacer 112 once removed from the catheter, permitting the spokes 124 to engage the wall of left atrial appendage 210. In addition, the spokes 124 are formed sufficiently long and disposed at an angle away from the body 114 of the atrial pacer 112 to cause the second ends 127 of the spokes 124 to be biased against the wall of the left atrial appendage 210 to retain the cardiac stimulating device 100 in position. For example, the spokes 125 may have a length to allow the second ends 127 of the spokes 124 to terminate proximate the left atrial appendage opening. The spokes 124 are attached to the atrial pacer 112 at such a location as to permit the spokes 124 to partially occlude the opening of the left atrial appendage and to permit the first end 118 of the atrial pacer 112 to contact the wall of the atrial appendage 210.
In each of the above embodiments, the atrial pacer 12, 112 may include a power source 16, 116, such as a rechargeable battery, within the generally elongated body 14, 114 along with appropriate circuitry known for the operation of atrial sensing and stimulating devices. Alternatively or additionally, the cardiac stimulating device 10, 100 may include a lead wire 32, 132 to provide power and/or a control signal to the atrial pacer 12, 112 from a remote device. A
control unit for use external to the left atrial appendage 210, or external to a patient's body, may be provided for housing circuitry of the atrial pacer 12, 112.
Providing such a control unit may also be desirable, since inclusion of control circuitry therein may permit the atrial pacer 12, 112 to have a smaller overall the size.
Referring to Figs. 5-7, three exemplary embodiments are shown of device arrangements which include remote control and/or power supply units.
In particular, with regard to Fig. 5, a control unit 302 is shown for controlling and powering the stimulator 308 of an atrial pacer. The stimulator 308 may correspond to the stimulating devices 23, 123 depicted in Figs. 1 and 2 as described above. In the configuration of Fig. 5, a sensor 304 is incorporated in a remotely located control unit 302 rather than in the elongated body 14, 114 of the atrial pacer 12, 112. The sensor 304 is in sensing contact with the left atrial appendage 210 via lead wire 306 to detect NRAF in the atrial appendage 210.
Hence, for this configuration the sensing device 22, 122 described above as being disposed within the first end 18, 118 of the atrial pacer 12,112 is not required to be disposed therein.
The control unit 302 further includes control circuitry 310 for processing the signal detected by the sensor 304 and controlling the stimulator 308 in response to the detected signal. For example, when the control circuitry 310 receives a signal from the sensor 304 indicative of NRAF of the left atrial appendage 210, the control circuitry delivers a control signal to the stimulator 308 to cause the stimulator 308 to stimulate the left atrial appendage 210 to alleviate the NRAF. Hence, by correcting NRAF, formation of blood clots in the left atrial appendage 210 is reduced by limiting the presence of stagnant blood in the left atrial appendage 210. The control unit 302 communicates with the stimulator 308 via an optional lead wire 309 or via wireless communication.
Wireless communication can be effected via optional antennas 314, 315 connected to the control unit 302 and the stimulator 308, respectively. The antenna 315 of the stimulator 308 may be disposed, for example, at the second end 30, 130 of the atrial pacer 12, 112. The control unit 302 may include a power source 312 to power the control unit 302 and to optionally power the stimulator 308 via lead wire 307.
Referring to Fig. 6, a further embodiment of the present invention is shown which is substantially similar to that shown in Fig. 5. The embodiment of Fig. 6 differs from Fig. 5 in that the control unit 402 of Fig. 6 does not include a sensor. Instead, a sensor 404 is provided in the elongated body 14, 114 of the atrial pacer 12, 112 along with a stimulator 408. Such a sensor 404 may correspond to the sensing devices 22, 122 shown in Figs. 1 and 2 and described above. Since the sensor 404 and stimulator 408 are both disposed within the body 14, 114 of the atrial pacer 12, 112, the sensor 404 and stimulator 408 may communicate directly with each other so that the stimulator 408 may stimulate left atrial appendage 210 in response to the detection of NRAF by the sensor 404. Alternatively, to minimize the size of the atrial pacer, control circuitry may be provided in a remote control unit 402 to receive data from the sensor 404, to process such data, and control the stimulator 408 in response to such data. Communication between the control unit 402 and the stimulator 408 and sensor 404 may be effected via an optional lead wire 409 or via wireless communication using optional antennas 414, 415, in a similar manner to that described above with regard to the embodiment of Fig. 5.
In addition, as shown in Fig. 7, the atrial pacer 512 may be configured to be recharged by a remote charger 506. In such an embodiment, the atrial pacer 512 includes a first electrical coil 502 electrically coupled to an energizer unit 516, such as a battery, of the atrial pacer 512. The recharger 506 has a corresponding second electrical coil 504 which may be electromagnetically coupled to the first coil 502 to transmit electromagnetic energy thereto from the charger 506, through the patient's skin 508, and thence into the energizer unit 516 of the atrial pacer 512.
After insertion of the cardiac stimulating device 10, 100 into the heart so that the filtration device 28, 126 expands and sensing device 22, 122 or sensor 304, 404 is placed in sensing contact with the left atrial appendage 210, the cardiac stimulating device 10, 100 monitors for the presence of NRAF. Upon detection of NRAF, the stimulator 23, 123 applies a correcting stimulating electrical signal to the left atrial appendage 210 in response to the detected NRAF condition. By such treatment of the left atrial appendage 210 to minimize NRAF, the formation of blood clots attributable to NRAF is minimized. In addition, the presence of the filtration device 28, 126 provides continuous filtration of the blood exiting the left atrial appendage 210, so as to prevent the egress of emboli therefrom.
These and other advantages of the present invention will be apparent to those skilled in the art. Accordingly, it will be recognized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. For example, the atrial pacer could be replaced and/or adapted to function as a ventricular defibrillator to treat ventricular tachycardia.
Likewise, the atrial pacer could be replaced by a device that functions as a combined atrial pacer and ventricular defibrillator. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intended to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.
Detailed Description Of The Invention A cardiac stimulating apparatus 10, 100 is provided for substantially reducing the formation of blood clots in an atrial appendage of a heart, such as the left atrial appendage 210, and reducing the migration of such clots into the blood vessel system of a patient. The apparatus 10, 100 comprises a filtration device 28, 124 to reduce migration of embolic material, such as blood clots or the like. In addition, the apparatus 10, 100 includes an atrial pacer 12, 112 to treat arrythmias, such as non-rheumatic atrial fibrillation (NRAF), of the left atrial appendage 210 to deter the formation blood clots within the left atrial appendage 210. Figures 1-4 depict the general structure of a cardiac stimulating apparatus of the present invention, illustrating the cooperation between the atrial pacer 12, 112 and the filtration device, such as filter 28 or spokes 124.
Turning now to Figs. 1 and 3, an embodiment of the present invention is shown in which a cardiac stimulating apparatus 10 comprises an atrial pacer 12 having an elongated generally tubular body 14 having first and second opposing ends 18, 30. The first end 18 of the atrial pacer 12 is adapted to contact the wall of the left atrial appendage 210 to support the cardiac stimulating apparatus within the left atrial appendage 210. The first end 18 may include a sensing device 22 optionally disposed therein to detect NRAF or other arrhythmias in the left atrial appendage 210. In such a configuration, the sensing device 22 is adapted to be in sensing contact with the wall of the left atrial appendage 210.
The first end 18 of the atrial pacer 12 also includes a stimulating device 23 for stimulating the left atrial appendage 210 in response to detection of NRAF by a detector, such as sensing device 22. The stimulating device 23 includes an electrode adapted to be in electrical contact with the wall of the atrial appendage 210 for applying stimulating signals to the atrial appendage 210. By application of an appropriate stimulating signal, NRAF can be reduced or eliminated thereby reducing the tendency of blood within the left atrial appendage 210 to form blood clots. The sensing device 22 and stimulating device 23 may comprise components known for use in atrial pacers.
Extending outwardly from the elongated generally tubular body 14, a filtration device is provided to deter the migration of blood clots from the left atrial appendage 210 into the left atrium 200 of the heart. As shown in Fig.
l, an embodiment of the filtration device may take the form of a mesh-like or sieve-like filter 28. The filter 28 may have a generally conical shape as shown, for example, with the narrower end of the conical filter 28 attached to the atrial pacer 12 proximate to the first end 18 of the atrial pacer 12. Alternatively, the filter 28 may be attached to the atrial pacer 12 at any point along the elongated body 14. The filter 28 may have any shape suited to substantially fill the opening defined by the intersection of the left atrial appendage 210 and the left atrium 200, such as a portion of a sphere, flat sheet, or other shape.
The mesh-like material of the filter 28 may be formed from a metal, such as a stainless-steel, for example. Alternatively, the filter 28 may be formed from a polymeric material, such as a Nylon or Dacron mesh. Other suitable materials such as PTFE or polyamides may also be used. In particular, it is preferable that the filter 28 be formed of a resilient material capable of being collapsed about the body 14 of the atrial pacer 12, as shown in Fig. 8, to facilitate introduction of the cardiac stimulating device 10 into a patient, for example, via a catheter.
The resilient material is chosen such that upon removal of the cardiac stimulating device 10 from the catheter, the filter 28 expands to a desired shape and size to permit the opening of the left atrial appendage 210 to be substantially sealed.
Regardless of the material from which the filter 28 is formed, the filter 28 is formed to provide pores having a transverse dimensions of about 1 mm or other size sufficiently small to prevent the passage of blood clots or other thromboembolic material of like or greater size. In particular, it may be desirable for the pore size to have a transverse dimension up to about 0.1 mm.
The wider end of the filter 28 includes a rim portion 20 which defines the base of the filter 28. The rim portion 20 is sized to circumscribe the opening between the left atrial appendage 210 and left atrium 200, so that emplacement the cardiac stimulating device 10 in the left atrial appendage 210 generally positions the rim portion 20 near the opening left atrial appendage 210 so as to form and maintain a seal therewith. To effect and maintain such a seal, the rim portion 20 may be formed of or covered by a soft polymer material. The rim portion 20 may have a transverse dimension of about 2 to 40 mm, preferably about 25 to 35 mm. The transverse dimension of the rim portion 20 should be selected with regard to the size of the left atrial appendage opening, which may vary among patients, especially those patients having heart disease related conditions.
The rim portion 20 may also include a plurality of holes through which sutures may be placed to anchor the rim portion 20 proximate to the opening of the left atrial appendage 210. Alternatively or additionally, the rim portion may have a spring-like action which causes the rim portion 20 to expand generally radially outward from the longitudinal axis of the atrial pacer 12, so that the rim portion 20 applies pressure against a region proximate the opening of the left atrial appendage 210 to form a seal proximate the opening of the left atrial appendage 210. For example, the rim portion 20 may be formed of a shape memory metal, such as NiTi, having a memorized shape larger than that of the opening of the left atrial appendage 210 to supply the radially outward pressure on the opening. The filter 28 is attached to the atrial pacer 12 at such a location so as to permit the rim portion 20 to substantially form a seal within the left atrial appendage opening and to permit the first end 18 of the atrial pacer 12 to contact the wall of the atrial appendage 210.
Referring now to Figs. 2 and 4, an alternative embodiment of the cardiac stimulating apparatus 100 is shown where the filtration device comprises a plurality of spokes 124 extending generally radially outwardly from the atrial pacer 112, to deter the migration of blood clots from the left atrial appendage 210 of the heart to the left atrium 200 of the heart. The atrial pacer 112 of the alternative embodiment comprises an elongated generally tubular body 114 having first and second ends 118, 130, a stimulating device 123, and an optional sensing device 122 similar to like components 23 and 22 described above with regard to the previous embodiment.
The spokes 124 each comprise a first end 125 attached to the elongated body 114 of the atrial pacer 112 and a second end 127 of the spokes 124 for engaging a region of the heart in the vicinity of the left atrial appendage 210.
The second end 127 of the spokes 124 may terminate in a hook-like tine 126 formed to anchor the spokes 124 and retain the atrial pacer 112 within the left atrial appendage 210. In addition, all or some of the second ends 127 of the spokes 124 may include a hole suitable for placing a suture therethrough for attachment to the left atrial appendage 210. The number of spokes 124 employed should be sufficiently numerous to create interstices between the spokes 124 sufficiently small to deter the passage of embolic material through the interstices.
The first ends 125 of the plurality a spokes 124 may be attached to the body 114 of the atrial pacer 112 at a common distance from the first end 118 of the atrial pacer 112. Alternatively, the first ends 125 of the plurality of spokes 124 may be attached to the body 114 of the atrial pacer 112 at varying distances from the first end 118 of the atrial pacer 112. Providing spokes 124 at a variety of distances from the first end 118 of the atrial pacer 112 may be useful to create a tortuous path to deter the flow of embolic material. For example, a first set of spokes 124 may have first ends 125 adjoining the atrial pacer 112 at a common distance from the first end 118 around the circumference of the atrial pacer 112.
A second set of spokes may have first ends adjoining the atrial pacer 112 at a further distance from the first end 118 of the atrial pacer 112 than the first set of spokes 124. In addition, the second set of spokes may be oriented circumferentially to overlap with the interstices formed among the first set of spokes 124, as viewed from the first end 118 of the atrial pacer 112.
Likewise, additional set of spokes 124 may be included to effect additional blockage of embolic material flow. Moreover, some or all of the spokes 124 may extend outwardly from the atrial pacer 112 along non-radial directions, to enhance blockage of embolic material.
The spokes 124 may be formed of any suitable material such as a metal or polymeric material like those described above with regard to the mesh-like filter 28. It is also desirable that the spokes 124 be sufficiently pliable to permit the spokes 124 to be disposed along the body 114 of the atrial pacer 112, as shown in Fig. 9, while the cardiac stimulating device 100 is placed into a patient via a catheter.
In addition, it is desirable that the spokes 124 be sufficiently resilient so that they expand away from the body 114 of the atrial pacer 112 once removed from the catheter, permitting the spokes 124 to engage the wall of left atrial appendage 210. In addition, the spokes 124 are formed sufficiently long and disposed at an angle away from the body 114 of the atrial pacer 112 to cause the second ends 127 of the spokes 124 to be biased against the wall of the left atrial appendage 210 to retain the cardiac stimulating device 100 in position. For example, the spokes 125 may have a length to allow the second ends 127 of the spokes 124 to terminate proximate the left atrial appendage opening. The spokes 124 are attached to the atrial pacer 112 at such a location as to permit the spokes 124 to partially occlude the opening of the left atrial appendage and to permit the first end 118 of the atrial pacer 112 to contact the wall of the atrial appendage 210.
In each of the above embodiments, the atrial pacer 12, 112 may include a power source 16, 116, such as a rechargeable battery, within the generally elongated body 14, 114 along with appropriate circuitry known for the operation of atrial sensing and stimulating devices. Alternatively or additionally, the cardiac stimulating device 10, 100 may include a lead wire 32, 132 to provide power and/or a control signal to the atrial pacer 12, 112 from a remote device. A
control unit for use external to the left atrial appendage 210, or external to a patient's body, may be provided for housing circuitry of the atrial pacer 12, 112.
Providing such a control unit may also be desirable, since inclusion of control circuitry therein may permit the atrial pacer 12, 112 to have a smaller overall the size.
Referring to Figs. 5-7, three exemplary embodiments are shown of device arrangements which include remote control and/or power supply units.
In particular, with regard to Fig. 5, a control unit 302 is shown for controlling and powering the stimulator 308 of an atrial pacer. The stimulator 308 may correspond to the stimulating devices 23, 123 depicted in Figs. 1 and 2 as described above. In the configuration of Fig. 5, a sensor 304 is incorporated in a remotely located control unit 302 rather than in the elongated body 14, 114 of the atrial pacer 12, 112. The sensor 304 is in sensing contact with the left atrial appendage 210 via lead wire 306 to detect NRAF in the atrial appendage 210.
Hence, for this configuration the sensing device 22, 122 described above as being disposed within the first end 18, 118 of the atrial pacer 12,112 is not required to be disposed therein.
The control unit 302 further includes control circuitry 310 for processing the signal detected by the sensor 304 and controlling the stimulator 308 in response to the detected signal. For example, when the control circuitry 310 receives a signal from the sensor 304 indicative of NRAF of the left atrial appendage 210, the control circuitry delivers a control signal to the stimulator 308 to cause the stimulator 308 to stimulate the left atrial appendage 210 to alleviate the NRAF. Hence, by correcting NRAF, formation of blood clots in the left atrial appendage 210 is reduced by limiting the presence of stagnant blood in the left atrial appendage 210. The control unit 302 communicates with the stimulator 308 via an optional lead wire 309 or via wireless communication.
Wireless communication can be effected via optional antennas 314, 315 connected to the control unit 302 and the stimulator 308, respectively. The antenna 315 of the stimulator 308 may be disposed, for example, at the second end 30, 130 of the atrial pacer 12, 112. The control unit 302 may include a power source 312 to power the control unit 302 and to optionally power the stimulator 308 via lead wire 307.
Referring to Fig. 6, a further embodiment of the present invention is shown which is substantially similar to that shown in Fig. 5. The embodiment of Fig. 6 differs from Fig. 5 in that the control unit 402 of Fig. 6 does not include a sensor. Instead, a sensor 404 is provided in the elongated body 14, 114 of the atrial pacer 12, 112 along with a stimulator 408. Such a sensor 404 may correspond to the sensing devices 22, 122 shown in Figs. 1 and 2 and described above. Since the sensor 404 and stimulator 408 are both disposed within the body 14, 114 of the atrial pacer 12, 112, the sensor 404 and stimulator 408 may communicate directly with each other so that the stimulator 408 may stimulate left atrial appendage 210 in response to the detection of NRAF by the sensor 404. Alternatively, to minimize the size of the atrial pacer, control circuitry may be provided in a remote control unit 402 to receive data from the sensor 404, to process such data, and control the stimulator 408 in response to such data. Communication between the control unit 402 and the stimulator 408 and sensor 404 may be effected via an optional lead wire 409 or via wireless communication using optional antennas 414, 415, in a similar manner to that described above with regard to the embodiment of Fig. 5.
In addition, as shown in Fig. 7, the atrial pacer 512 may be configured to be recharged by a remote charger 506. In such an embodiment, the atrial pacer 512 includes a first electrical coil 502 electrically coupled to an energizer unit 516, such as a battery, of the atrial pacer 512. The recharger 506 has a corresponding second electrical coil 504 which may be electromagnetically coupled to the first coil 502 to transmit electromagnetic energy thereto from the charger 506, through the patient's skin 508, and thence into the energizer unit 516 of the atrial pacer 512.
After insertion of the cardiac stimulating device 10, 100 into the heart so that the filtration device 28, 126 expands and sensing device 22, 122 or sensor 304, 404 is placed in sensing contact with the left atrial appendage 210, the cardiac stimulating device 10, 100 monitors for the presence of NRAF. Upon detection of NRAF, the stimulator 23, 123 applies a correcting stimulating electrical signal to the left atrial appendage 210 in response to the detected NRAF condition. By such treatment of the left atrial appendage 210 to minimize NRAF, the formation of blood clots attributable to NRAF is minimized. In addition, the presence of the filtration device 28, 126 provides continuous filtration of the blood exiting the left atrial appendage 210, so as to prevent the egress of emboli therefrom.
These and other advantages of the present invention will be apparent to those skilled in the art. Accordingly, it will be recognized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. For example, the atrial pacer could be replaced and/or adapted to function as a ventricular defibrillator to treat ventricular tachycardia.
Likewise, the atrial pacer could be replaced by a device that functions as a combined atrial pacer and ventricular defibrillator. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intended to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.
Claims (87)
1. A cardiac stimulating apparatus, comprising:
a filter adapted to substantially prevent transport of emboli from an atrial appendage to an atrium of the heart; and an atrial pacer to support the filter between the atrial appendage and the atrium, the atrial pacer adapted to be in sensing contact with a wall of the atrial appendage to reduce atrial fibrillation in the atrial appendage.
a filter adapted to substantially prevent transport of emboli from an atrial appendage to an atrium of the heart; and an atrial pacer to support the filter between the atrial appendage and the atrium, the atrial pacer adapted to be in sensing contact with a wall of the atrial appendage to reduce atrial fibrillation in the atrial appendage.
2. The cardiac stimulating apparatus according to claim 1 wherein the filter comprises a plurality of spokes.
3. The cardiac stimulating apparatus according to claim 2 wherein the spokes include tines to attach the filter to the atrial appendage.
4. The cardiac stimulating apparatus according to claim 1 wherein the spokes extend generally radially outwardly from the atrial pacer.
5. The cardiac stimulating apparatus according to claim 1 wherein the filter comprises a mesh.
6. The cardiac stimulating apparatus according to claim 1 wherein the filter includes at least one of an expandable mesh and a plurality of expandable spokes.
7. The cardiac stimulating apparatus according to claim 6 wherein said one of said expendable mesh and said plurality of expendable spokes are collapsible to be disposed near the atrial pacer for implantation into the atrial appendage through a catheter.
8. The cardiac stimulating apparatus according to claim 1 wherein atrial pacer includes a control unit adapted to be disposed external to the heart.
9. The cardiac stimulating apparatus according to claim 8 wherein, the control unit includes a sensor adapted to be in sensing contact with the wall of the atrial appendage.
10. The cardiac stimulating apparatus according to claim 9 wherein the control unit is adapted to be in wireless communication with the sensor.
11. The cardiac stimulating apparatus according to claim 8 wherein the control unit comprises circuitry for providing a control signal to control the atrial pacer.
12. The cardiac stimulating apparatus according to claim 8 wherein the atrial pacer includes a stimulator adapted to be disposed interior to the heart for applying a stimulating signal to the wall of the atrial appendage.
13. The cardiac stimulating apparatus according to claim 12 wherein the control unit is adapted to be in wireless communication with the stimulator.
14. The cardiac stimulating apparatus according to claim 1 wherein the atrial pacer includes at least one of a stimulator disposed therein for applying a stimulating signal to the wall of the atrial appendage and a sensor disposed therein to be in sensing contact with a wall of the atrial appendage.
15. The cardiac stimulating apparatus according to claim 1 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
16. The cardiac stimulating apparatus according to claim 15 wherein the charger and the energizer are in wireless communication.
17. The cardiac stimulating apparatus according to claim 15 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
18. A cardiac stimulating apparatus, comprising:
a filter adapted to engage proximate an opening between an atrial appendage and an atrium of a heart; and an atrial pacer to support the filter proximate the opening between the atrial appendage and the atrium, comprising i) a sensor adapted to be in sensing contact with a wall of the atrial appendage for sensing fibrillation of the atrial appendage, and ii) an electrode adapted to be in electrical contact with the wall of the atrial appendage for applying stimulating signals to the atrial appendage.
a filter adapted to engage proximate an opening between an atrial appendage and an atrium of a heart; and an atrial pacer to support the filter proximate the opening between the atrial appendage and the atrium, comprising i) a sensor adapted to be in sensing contact with a wall of the atrial appendage for sensing fibrillation of the atrial appendage, and ii) an electrode adapted to be in electrical contact with the wall of the atrial appendage for applying stimulating signals to the atrial appendage.
19. The cardiac stimulating apparatus according to claim 18 wherein the filter comprises a plurality of spokes.
20. The cardiac stimulating apparatus according to claim 19 wherein the spokes include tines to attach the filter to the atrial appendage.
21. The cardiac stimulating apparatus according to claim 18 wherein the spokes extend generally radially outwardly from the atrial pacer.
22. The cardiac stimulating apparatus according to claim 18 wherein the filter comprises a mesh.
23. The cardiac stimulating apparatus according to claim 18 wherein the filter includes at least one of an expandable mesh and a plurality of expandable spokes.
24. The cardiac stimulating apparatus according to claim 23 wherein said one of said expendable mesh and said plurality of expendable spokes are collapsible to be disposed near the atrial pacer for implantation into the atrial appendage through a catheter.
25. The cardiac stimulating apparatus according to claim 18 wherein atrial pacer includes a control unit adapted to be disposed external to the heart.
26. The cardiac stimulating apparatus according to claim 25 wherein the control unit is adapted to be in wireless communication with the sensor.
27. The cardiac stimulating apparatus according to claim 12 wherein the control unit is adapted to be in wireless communication with the electrode.
28. The cardiac stimulating apparatus according to claim 25 wherein the control unit comprises circuitry for providing a control signal to control the atrial pacer.
29. The cardiac stimulating apparatus according to claim 18 wherein the atrial pacer includes a stimulator for providing a stimulation control signal to the electrode.
30. The cardiac stimulating apparatus according to claim 18 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
31. The cardiac stimulating apparatus according to claim 30 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
32. A cardiac stimulating apparatus, comprising:
a filtration device for reducing the transport of emboli from an atrial appendage to an atrium of the heart; and an atrial pacer to support the filtration device between the atrial appendage and the atrium, the atrial pacer adapted to contact a wall of the atrial appendage for reducing atrial fibrillation in the atrial appendage.
a filtration device for reducing the transport of emboli from an atrial appendage to an atrium of the heart; and an atrial pacer to support the filtration device between the atrial appendage and the atrium, the atrial pacer adapted to contact a wall of the atrial appendage for reducing atrial fibrillation in the atrial appendage.
33. The cardiac stimulating apparatus according to claim 32 wherein the filtration device comprises a plurality of spokes.
34. The cardiac stimulating apparatus according to claim 33 wherein the spokes include tines to attach the filtration device to the atrial appendage.
35. The cardiac stimulating apparatus according to claim 32 wherein the spokes extend generally radially outwardly from the atrial pacer.
36. The cardiac stimulating apparatus according to claim 32 wherein the filtration device comprises a mesh.
37. The cardiac stimulating apparatus according to claim 32 wherein the filtration device includes at least one of an expandable mesh and a plurality of expandable spokes.
38. The cardiac stimulating apparatus according to claim 37 wherein said one of said expendable mesh and said plurality of expendable spokes are collapsible to be disposed near the atrial pacer for implantation into the atrial appendage through a catheter.
39. The cardiac stimulating apparatus according to claim 32 wherein atrial pacer includes a control unit adapted to be disposed external to the heart.
40. The cardiac stimulating apparatus according to claim 39 wherein, the control unit includes a sensor adapted to be in sensing contact with the wall of the atrial appendage.
41. The cardiac stimulating apparatus according to claim 40 wherein the control unit is adapted to be in wireless communication with the sensor.
42. The cardiac stimulating apparatus according to claim 39 wherein the control unit comprises circuitry for providing a control signal to control the atrial pacer.
43. The cardiac stimulating apparatus according to claim 39 wherein the atrial pacer includes a stimulator adapted to be disposed interior to the heart for applying a stimulating signal to the wall of the atrial appendage.
44. The cardiac stimulating apparatus according to claim 43 wherein the control unit is adapted to be in wireless communication with the stimulator.
45. The cardiac stimulating apparatus according to claim 32 wherein the atrial pacer includes at least one of a stimulator disposed therein for applying a stimulating signal to the wall of the atrial appendage and a sensor disposed therein to be in sensing contact with a wall of the atrial appendage.
46. The cardiac stimulating apparatus according to claim 32 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
47. The cardiac stimulating apparatus according to claim 46 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
48. A cardiac stimulating apparatus comprising:
an atrial pacer comprising an elongated body adapted at one end thereof for making at least one of sensing and stimulating contact with a wall of an atrial appendage of a heart, said atrial pacer including at least one of an atrial sensor and an atrial stimulator; and an filtration device mounted to said elongated body distal the one end thereof and adapted for intercepting emboli moving between the atrial appendage and an atrium of the heart.
an atrial pacer comprising an elongated body adapted at one end thereof for making at least one of sensing and stimulating contact with a wall of an atrial appendage of a heart, said atrial pacer including at least one of an atrial sensor and an atrial stimulator; and an filtration device mounted to said elongated body distal the one end thereof and adapted for intercepting emboli moving between the atrial appendage and an atrium of the heart.
49. The cardiac stimulating apparatus according to claim 48 wherein the filtration device comprises a plurality of spokes.
50. The cardiac stimulating apparatus according to claim 49 wherein the spokes include tines to attach the filtration device to the atrial appendage.
51. The cardiac stimulating apparatus according to claim 48 wherein the spokes extend generally radially outwardly from the atrial pacer.
52. The cardiac stimulating apparatus according to claim 48 wherein the filtration device comprises a mesh.
53. The cardiac stimulating apparatus according to claim 48 wherein the filtration device includes at least one of an expandable mesh and a plurality of expandable spokes.
54. The cardiac stimulating apparatus according to claim 53 wherein said one of said expendable mesh and said plurality of expendable spokes are collapsible to be disposed near the atrial pacer for implantation into the atrial appendage through a catheter.
55. The cardiac stimulating apparatus according to claim 48 wherein atrial pacer includes a control unit adapted to be disposed external to the heart.
56. The cardiac stimulating apparatus according to claim 55 wherein the control unit is adapted to be in wireless communication with the atrial sensor.
57. The cardiac stimulating apparatus according to claim 55 wherein the control unit is adapted to be in wireless communication with the stimulator.
58. The cardiac stimulating apparatus according to claim 48 wherein the stimulator is adapted to apply a stimulating signal to the wall of the atrial appendage and the sensor is adapted to be in sensing contact with a wall of the atrial appendage.
59. The cardiac stimulating apparatus according to claim 48 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
60. The cardiac stimulating apparatus according to claim 59 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
61. A cardiac stimulating apparatus comprising:
an atrial pacer comprising an elongated body adapted at one end thereof for making at least one of sensing and stimulating contact with a wall of an atrial appendage of a heart, said atrial pacer including an atrial sensor and an atrial stimulator disposed in said elongated body; and an filtration device mounted to said elongated body distal the one end thereof and adapted for intercepting emboli moving between the atrial appendage and an atrium of the heart.
an atrial pacer comprising an elongated body adapted at one end thereof for making at least one of sensing and stimulating contact with a wall of an atrial appendage of a heart, said atrial pacer including an atrial sensor and an atrial stimulator disposed in said elongated body; and an filtration device mounted to said elongated body distal the one end thereof and adapted for intercepting emboli moving between the atrial appendage and an atrium of the heart.
62. The cardiac stimulating apparatus according to claim 61 wherein the filtration device comprises a plurality of spokes.
63. The cardiac stimulating apparatus according to claim 62 wherein the spokes include tines to attach the filtration device to the atrial appendage.
64. The cardiac stimulating apparatus according to claim 61 wherein the spokes extend generally radially outwardly from the atrial pacer.
65. The cardiac stimulating apparatus according to claim 61 wherein the filtration device comprises a mesh.
66. The cardiac stimulating apparatus according to claim 61 wherein the filtration device includes at least one of an expandable mesh and a plurality of expandable spokes.
67. The cardiac stimulating apparatus according to claim 66 wherein said one of said expendable mesh and said plurality of expendable spokes are collapsible to be disposed near the atrial pacer for implantation into the atrial appendage through a catheter.
68. The cardiac stimulating apparatus according to claim 61 wherein the atrial pacer includes a control unit adapted to be disposed external to the heart.
69. The cardiac stimulating apparatus according to claim 68 wherein the control unit is adapted to be in wireless communication with the sensor.
70. The cardiac stimulating apparatus according to claim 68 wherein the control unit is adapted to be in wireless communication with the stimulator.
71. The cardiac stimulating apparatus according to claim 61 wherein the stimulator is adapted to apply a stimulating signal to the wall of the atrial appendage and the sensor is adapted to be in sensing contact with a wall of the atrial appendage.
72. The cardiac stimulating apparatus according to claim 61 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said atrial pacer.
73. The cardiac stimulating apparatus according to claim 72 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
74. A cardiac stimulating apparatus, comprising:
a filtration means for reducing the transport of emboli from an atrial appendage to an atrium of the heart; and a pacing means for supporting the filtration device between the atrial appendage and the atrium and for reducing atrial fibrillation in the atrial appendage.
a filtration means for reducing the transport of emboli from an atrial appendage to an atrium of the heart; and a pacing means for supporting the filtration device between the atrial appendage and the atrium and for reducing atrial fibrillation in the atrial appendage.
75. ~The cardiac stimulating apparatus according to claim 74 wherein the filtration means comprises a plurality of spokes.
76. ~The cardiac stimulating apparatus according to claim 74 wherein the spokes extend generally radially outwardly from the pacing means.
77. ~The cardiac stimulating apparatus according to claim 74 wherein the filtration means comprises a mesh.
78. ~The cardiac stimulating apparatus according to claim 74 wherein the filtration means includes at least one of an expandable mesh and a plurality of expandable spokes.
79. ~The cardiac stimulating apparatus according to claim 78 wherein said one of said expendable mesh and said plurality of expendable spokes are collapsible to be disposed near the pacing means for implantation into the atrial appendage through a catheter.
80. ~The cardiac stimulating apparatus according to claim 74 wherein pacing means includes a control unit adapted to be disposed external to the heart.
81. ~The cardiac stimulating apparatus according to claim 80 wherein, the control unit includes a sensor adapted to be in sensing contact with the wall of the atrial appendage.
82. ~The cardiac stimulating apparatus according to claim 81 wherein the control unit is adapted to be in wireless communication with the sensor.
83. ~The cardiac stimulating apparatus according to claim 80 wherein the pacing means includes a stimulator adapted to be disposed interior to the heart for applying a stimulating signal to the wall of the atrial appendage.
84. ~The cardiac stimulating apparatus according to claim 83 wherein the control unit is adapted to be in wireless communication with the stimulator.
85. ~The cardiac stimulating apparatus according to claim 74 wherein the pacing means includes at least one of a stimulator disposed therein for applying a stimulating signal to the wall of the atrial appendage and a sensor disposed therein to be in sensing contact with a wall of the atrial appendage.
86. ~The cardiac stimulating apparatus according to claim 74 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said pacing means.
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said pacing means.
87. ~The cardiac stimulating apparatus according to claim 86 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29568301P | 2001-06-04 | 2001-06-04 | |
US60/295,683 | 2001-06-04 | ||
PCT/US2002/017704 WO2002098282A2 (en) | 2001-06-04 | 2002-06-04 | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2449468A1 true CA2449468A1 (en) | 2002-12-12 |
Family
ID=23138789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2449468 Abandoned CA2449468A1 (en) | 2001-06-04 | 2002-06-04 | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
Country Status (5)
Country | Link |
---|---|
US (2) | US6941169B2 (en) |
EP (1) | EP1392394A4 (en) |
JP (1) | JP2005508208A (en) |
CA (1) | CA2449468A1 (en) |
WO (1) | WO2002098282A2 (en) |
Families Citing this family (182)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6714967B1 (en) | 1999-07-30 | 2004-03-30 | Microsoft Corporation | Integration of a computer-based message priority system with mobile electronic devices |
US8961541B2 (en) | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
US20080114394A1 (en) | 2001-04-24 | 2008-05-15 | Houser Russell A | Arteriotomy Closure Devices and Techniques |
US20090143808A1 (en) * | 2001-04-24 | 2009-06-04 | Houser Russell A | Guided Tissue Cutting Device, Method of Use and Kits Therefor |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
WO2003053493A2 (en) | 2001-12-19 | 2003-07-03 | Nmt Medical, Inc. | Septal occluder and associated methods |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
WO2003082076A2 (en) | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
WO2003103476A2 (en) | 2002-06-05 | 2003-12-18 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure device with radial and circumferential support |
US20040147973A1 (en) * | 2002-06-27 | 2004-07-29 | Hauser Robert G. | Intra cardiac pacer and method |
WO2004037333A1 (en) | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
WO2004052213A1 (en) | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US7658747B2 (en) | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
US7082336B2 (en) * | 2003-06-04 | 2006-07-25 | Synecor, Llc | Implantable intravascular device for defibrillation and/or pacing |
US7617007B2 (en) | 2003-06-04 | 2009-11-10 | Synecor Llc | Method and apparatus for retaining medical implants within body vessels |
US8239045B2 (en) | 2003-06-04 | 2012-08-07 | Synecor Llc | Device and method for retaining a medical device within a vessel |
AU2004251673B2 (en) * | 2003-06-04 | 2010-01-28 | Synecor Llc | Intravascular electrophysiological system and methods |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US7678123B2 (en) | 2003-07-14 | 2010-03-16 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
DE602004017750D1 (en) | 2003-08-19 | 2008-12-24 | Nmt Medical Inc | Expandable lock hose |
DE602004009598T2 (en) * | 2003-09-12 | 2008-07-24 | NMT Medical, Inc., Boston | DEVICE FOR PREVENTING THE FORMATION OF THROMBAS IN THE LEFT PORTFOLIO |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US7747335B2 (en) | 2003-12-12 | 2010-06-29 | Synecor Llc | Implantable medical device having pre-implant exoskeleton |
US20110208233A1 (en) * | 2004-01-22 | 2011-08-25 | Mcguckin Jr James F | Device for preventing clot migration from left atrial appendage |
US20050192626A1 (en) | 2004-01-30 | 2005-09-01 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
US7871419B2 (en) | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US20050234540A1 (en) * | 2004-03-12 | 2005-10-20 | Nmt Medical, Inc. | Dilatation systems and methods for left atrial appendage |
US7806846B2 (en) * | 2004-03-30 | 2010-10-05 | Nmt Medical, Inc. | Restoration of flow in LAA via tubular conduit |
US20050234543A1 (en) * | 2004-03-30 | 2005-10-20 | Nmt Medical, Inc. | Plug for use in left atrial appendage |
CA2549323C (en) | 2004-04-08 | 2009-07-21 | Aga Medical Corporation | Flanged occlusion devices and methods |
US20050267524A1 (en) | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
JP2007535997A (en) | 2004-05-07 | 2007-12-13 | エヌエムティー メディカル, インコーポレイティッド | Capturing mechanism of tubular septal occluder |
WO2006036837A2 (en) | 2004-09-24 | 2006-04-06 | Nmt Medical, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
EP1868507A1 (en) | 2005-03-18 | 2007-12-26 | NMT Medical, Inc. | Catch member for pfo occluder |
US7962208B2 (en) * | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US8025668B2 (en) * | 2005-04-28 | 2011-09-27 | C. R. Bard, Inc. | Medical device removal system |
US8391990B2 (en) | 2005-05-18 | 2013-03-05 | Cardiac Pacemakers, Inc. | Modular antitachyarrhythmia therapy system |
US20070005097A1 (en) * | 2005-06-20 | 2007-01-04 | Renati Richard J | Intravascular filter |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US7848823B2 (en) * | 2005-12-09 | 2010-12-07 | Boston Scientific Scimed, Inc. | Cardiac stimulation system |
WO2007073566A1 (en) | 2005-12-22 | 2007-06-28 | Nmt Medical, Inc. | Catch members for occluder devices |
US7616992B2 (en) * | 2006-01-30 | 2009-11-10 | Medtronic, Inc. | Intravascular medical device |
US7627376B2 (en) * | 2006-01-30 | 2009-12-01 | Medtronic, Inc. | Intravascular medical device |
US7519424B2 (en) * | 2006-01-30 | 2009-04-14 | Medtronic, Inc. | Intravascular medical device |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
JP2009532125A (en) | 2006-03-31 | 2009-09-10 | エヌエムティー メディカル, インコーポレイティッド | Deformable flap catch mechanism for occluder equipment |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
WO2008131167A1 (en) | 2007-04-18 | 2008-10-30 | Nmt Medical, Inc. | Flexible catheter system |
EP2150181A1 (en) * | 2007-05-31 | 2010-02-10 | Rex Medical, L.P. | Closure device for left atrial appendage |
WO2008153653A1 (en) * | 2007-05-31 | 2008-12-18 | Rex Medical, L.P. | Fallopian tube occlusion device |
JP5581209B2 (en) * | 2007-07-18 | 2014-08-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Endoscopic implant system |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
JP5807970B2 (en) | 2009-04-09 | 2015-11-10 | カーディオバスキュラー テクノロジーズ、インク. | Tissue suturing device, transfer device and system, kit and method therefor |
US20100304209A1 (en) * | 2009-05-29 | 2010-12-02 | Medtronic, Inc. | Elongate battery for implantable medical device |
US8541131B2 (en) * | 2009-05-29 | 2013-09-24 | Medtronic, Inc. | Elongate battery for implantable medical device |
US20100305627A1 (en) * | 2009-05-29 | 2010-12-02 | Medtronic, Inc. | Battery with suture hole |
US9099720B2 (en) | 2009-05-29 | 2015-08-04 | Medtronic, Inc. | Elongate battery for implantable medical device |
US9636094B2 (en) | 2009-06-22 | 2017-05-02 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US20110082495A1 (en) * | 2009-10-02 | 2011-04-07 | Ruiz Carlos E | Apparatus And Methods For Excluding The Left Atrial Appendage |
US20110224495A1 (en) * | 2010-03-12 | 2011-09-15 | Tyco Healthcare Group Lp | Surgical access port |
EP2672927A4 (en) * | 2011-02-10 | 2014-08-20 | Atrial Innovations Inc | Atrial appendage occlusion and arrhythmia treatment |
EP2731493B1 (en) | 2011-07-11 | 2015-07-01 | The Regents of The University of Michigan | Multimodality left atrial appendage occlusion device |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
CN105246540A (en) | 2013-03-13 | 2016-01-13 | 阿龙·V·卡普兰 | Devices and methods for excluding left atrial appendage |
US10617425B2 (en) | 2014-03-10 | 2020-04-14 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11399842B2 (en) | 2013-03-13 | 2022-08-02 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US10300286B2 (en) | 2013-09-27 | 2019-05-28 | Medtronic, Inc. | Tools and assemblies thereof for implantable medical devices |
US9526522B2 (en) | 2013-09-27 | 2016-12-27 | Medtronic, Inc. | Interventional medical systems, tools, and assemblies |
ES2661718T3 (en) | 2014-01-10 | 2018-04-03 | Cardiac Pacemakers, Inc. | Methods and systems to improve communication between medical devices |
EP3092034B1 (en) | 2014-01-10 | 2019-10-30 | Cardiac Pacemakers, Inc. | Systems for detecting cardiac arrhythmias |
WO2015152741A1 (en) | 2014-03-31 | 2015-10-08 | Jitmed Sp. Z.O.O. | Left atrial appendage occlusion device |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US10478620B2 (en) | 2014-08-26 | 2019-11-19 | Medtronic, Inc. | Interventional medical systems, devices, and methods of use |
US9675798B2 (en) | 2014-08-26 | 2017-06-13 | Medtronic, Inc. | Interventional medical systems, devices, and components thereof |
US9526909B2 (en) | 2014-08-28 | 2016-12-27 | Cardiac Pacemakers, Inc. | Medical device with triggered blanking period |
EP3827877A1 (en) | 2015-02-06 | 2021-06-02 | Cardiac Pacemakers, Inc. | Systems for treating cardiac arrhythmias |
EP3253449B1 (en) | 2015-02-06 | 2018-12-12 | Cardiac Pacemakers, Inc. | Systems for safe delivery of electrical stimulation therapy |
US10046167B2 (en) | 2015-02-09 | 2018-08-14 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
WO2016141046A1 (en) | 2015-03-04 | 2016-09-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
WO2016149262A1 (en) | 2015-03-18 | 2016-09-22 | Cardiac Pacemakers, Inc. | Communications in a medical device system with link quality assessment |
US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
US9526891B2 (en) | 2015-04-24 | 2016-12-27 | Medtronic, Inc. | Intracardiac medical device |
US10357159B2 (en) | 2015-08-20 | 2019-07-23 | Cardiac Pacemakers, Inc | Systems and methods for communication between medical devices |
CN108136186B (en) | 2015-08-20 | 2021-09-17 | 心脏起搏器股份公司 | System and method for communication between medical devices |
US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10137305B2 (en) | 2015-08-28 | 2018-11-27 | Cardiac Pacemakers, Inc. | Systems and methods for behaviorally responsive signal detection and therapy delivery |
WO2017044389A1 (en) | 2015-09-11 | 2017-03-16 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
US10065041B2 (en) | 2015-10-08 | 2018-09-04 | Cardiac Pacemakers, Inc. | Devices and methods for adjusting pacing rates in an implantable medical device |
US10183170B2 (en) | 2015-12-17 | 2019-01-22 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
WO2017127548A1 (en) | 2016-01-19 | 2017-07-27 | Cardiac Pacemakers, Inc. | Devices for wirelessly recharging a rechargeable battery of an implantable medical device |
US10350423B2 (en) | 2016-02-04 | 2019-07-16 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
US10327809B2 (en) | 2016-02-29 | 2019-06-25 | Covidien Lp | Clip collar advanced fixation |
CN108883286B (en) | 2016-03-31 | 2021-12-07 | 心脏起搏器股份公司 | Implantable medical device with rechargeable battery |
US10143823B2 (en) | 2016-04-29 | 2018-12-04 | Medtronic, Inc. | Interventional medical systems and improved assemblies thereof and associated methods of use |
US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
CN109414582B (en) | 2016-06-27 | 2022-10-28 | 心脏起搏器股份公司 | Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves |
WO2018009569A1 (en) | 2016-07-06 | 2018-01-11 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US10426962B2 (en) | 2016-07-07 | 2019-10-01 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
US10688304B2 (en) | 2016-07-20 | 2020-06-23 | Cardiac Pacemakers, Inc. | Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US10391319B2 (en) | 2016-08-19 | 2019-08-27 | Cardiac Pacemakers, Inc. | Trans septal implantable medical device |
US10780278B2 (en) | 2016-08-24 | 2020-09-22 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing |
US10870008B2 (en) | 2016-08-24 | 2020-12-22 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
EP3515553B1 (en) | 2016-09-21 | 2020-08-26 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
US10994145B2 (en) | 2016-09-21 | 2021-05-04 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
WO2018081237A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Use of a separate device in managing the pace pulse energy of a cardiac pacemaker |
EP3531926A2 (en) | 2016-10-27 | 2019-09-04 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
JP7038115B2 (en) | 2016-10-27 | 2022-03-17 | カーディアック ペースメイカーズ, インコーポレイテッド | Implantable medical device with pressure sensor |
US11426172B2 (en) | 2016-10-27 | 2022-08-30 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US10758724B2 (en) | 2016-10-27 | 2020-09-01 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
WO2018081275A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
US10561330B2 (en) | 2016-10-27 | 2020-02-18 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
WO2018081721A1 (en) | 2016-10-31 | 2018-05-03 | Cardiac Pacemakers, Inc | Systems for activity level pacing |
CN109890456B (en) | 2016-10-31 | 2023-06-13 | 心脏起搏器股份公司 | System for activity level pacing |
WO2018089311A1 (en) | 2016-11-08 | 2018-05-17 | Cardiac Pacemakers, Inc | Implantable medical device for atrial deployment |
EP3538213B1 (en) | 2016-11-09 | 2023-04-12 | Cardiac Pacemakers, Inc. | Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device |
CN109963618B (en) | 2016-11-21 | 2023-07-04 | 心脏起搏器股份公司 | Leadless cardiac pacemaker with multi-mode communication |
US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
WO2018093605A1 (en) | 2016-11-21 | 2018-05-24 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker providing cardiac resynchronization therapy |
US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
US11147979B2 (en) | 2016-11-21 | 2021-10-19 | Cardiac Pacemakers, Inc. | Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing |
US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
US10737102B2 (en) | 2017-01-26 | 2020-08-11 | Cardiac Pacemakers, Inc. | Leadless implantable device with detachable fixation |
WO2018140623A1 (en) | 2017-01-26 | 2018-08-02 | Cardiac Pacemakers, Inc. | Leadless device with overmolded components |
EP3573706A1 (en) | 2017-01-26 | 2019-12-04 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
AU2018248361B2 (en) | 2017-04-03 | 2020-08-27 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate |
US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
WO2019036600A1 (en) | 2017-08-18 | 2019-02-21 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
US10918875B2 (en) | 2017-08-18 | 2021-02-16 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
CN111107899B (en) | 2017-09-20 | 2024-04-02 | 心脏起搏器股份公司 | Implantable medical device with multiple modes of operation |
EP3459469A1 (en) | 2017-09-23 | 2019-03-27 | Universität Zürich | Medical occluder device |
US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
EP3717060B1 (en) | 2017-12-01 | 2022-10-05 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with reversionary behavior |
EP3717059A1 (en) | 2017-12-01 | 2020-10-07 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker |
EP3717063B1 (en) | 2017-12-01 | 2023-12-27 | Cardiac Pacemakers, Inc. | Systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
CN111417433A (en) | 2017-12-01 | 2020-07-14 | 心脏起搏器股份公司 | Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker |
US20190175111A1 (en) * | 2017-12-04 | 2019-06-13 | 4C Medical Technologies, Inc. | Devices and methods for atrial mapping, sensing and treating cardiac arrhythmia |
CN111556773A (en) | 2018-01-04 | 2020-08-18 | 心脏起搏器股份公司 | Dual chamber pacing without beat-to-beat communication |
US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
WO2019178579A1 (en) * | 2018-03-16 | 2019-09-19 | Boston Scientific Scimed, Inc. | Devices for vein closure |
WO2019183512A1 (en) | 2018-03-23 | 2019-09-26 | Medtronic, Inc. | Vfa cardiac resynchronization therapy |
CN111936046A (en) | 2018-03-23 | 2020-11-13 | 美敦力公司 | VFA cardiac therapy for tachycardia |
CN111886046A (en) | 2018-03-23 | 2020-11-03 | 美敦力公司 | AV-synchronized VFA cardiac therapy |
CN110314282B (en) * | 2018-03-31 | 2023-08-04 | 长庚医疗财团法人林口长庚纪念医院 | Cardiac rhythm regulating device and cardiac rhythm regulating system |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
EP3856331A1 (en) | 2018-09-26 | 2021-08-04 | Medtronic, Inc. | Capture in ventricle-from-atrium cardiac therapy |
US11951313B2 (en) | 2018-11-17 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
WO2020163507A1 (en) | 2019-02-08 | 2020-08-13 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
EP3927423B1 (en) * | 2019-02-20 | 2023-12-13 | Ablation Innovations, LLC | Apparatus, systems, and methods to improve atrial fibrillation outcomes involving the left atrial appendage |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
JP2022549717A (en) | 2019-09-26 | 2022-11-28 | ウニベルシタット チューリッヒ | left atrial appendage closure device |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11903589B2 (en) | 2020-03-24 | 2024-02-20 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
US11801369B2 (en) | 2020-08-25 | 2023-10-31 | Shifamed Holdings, Llc | Adjustable interatrial shunts and associated systems and methods |
US11857197B2 (en) | 2020-11-12 | 2024-01-02 | Shifamed Holdings, Llc | Adjustable implantable devices and associated methods |
Family Cites Families (146)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US178283A (en) | 1876-06-06 | Improvement in vaginal syringes | ||
US1967318A (en) | 1931-10-02 | 1934-07-24 | Monahan William | Apparatus for the treatment of the urethra |
US3844302A (en) | 1970-09-14 | 1974-10-29 | Telesco Brophey Ltd | Collapsible umbrella |
US3946731A (en) | 1971-01-20 | 1976-03-30 | Lichtenstein Eric Stefan | Apparatus for extracorporeal treatment of blood |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US5904680A (en) * | 1992-09-25 | 1999-05-18 | Ep Technologies, Inc. | Multiple electrode support structures having optimal bio-mechanical characteristics |
US4007743A (en) | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4603693A (en) | 1977-05-26 | 1986-08-05 | United States Surgical Corporation | Instrument for circular surgical stapling of hollow body organs and disposable cartridge therefor |
US4166470A (en) | 1977-10-17 | 1979-09-04 | Medtronic, Inc. | Externally controlled and powered cardiac stimulating apparatus |
US4341218A (en) | 1978-05-30 | 1982-07-27 | University Of California | Detachable balloon catheter |
US4934383A (en) * | 1982-04-23 | 1990-06-19 | George Glumac | Electrode |
US4585000A (en) | 1983-09-28 | 1986-04-29 | Cordis Corporation | Expandable device for treating intravascular stenosis |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US5037810A (en) | 1987-03-17 | 1991-08-06 | Saliba Jr Michael J | Medical application for heparin and related molecules |
US4817600A (en) | 1987-05-22 | 1989-04-04 | Medi-Tech, Inc. | Implantable filter |
FR2632864B2 (en) | 1987-12-31 | 1990-10-19 | Biomat Sarl | ANTI-EMBOLIC ELASTIC FILTERING SYSTEM FOR CELLAR VEIN AND ASSEMBLY OF MEANS FOR ITS PLACEMENT |
US5041090A (en) | 1988-01-12 | 1991-08-20 | Scheglov Viktor I | Occluding device |
US4832055A (en) | 1988-07-08 | 1989-05-23 | Palestrant Aubrey M | Mechanically locking blood clot filter |
US6120437A (en) * | 1988-07-22 | 2000-09-19 | Inbae Yoon | Methods for creating spaces at obstructed sites endoscopically and methods therefor |
US4921484A (en) | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US4917089A (en) | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
FR2641692A1 (en) | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
DE8904371U1 (en) | 1989-04-07 | 1989-06-08 | Herzberg, Wolfgang, Dr. Med., 2000 Wedel, De | |
NL8901350A (en) * | 1989-05-29 | 1990-12-17 | Wouter Matthijs Muijs Van De M | CLOSURE ASSEMBLY. |
US5421832A (en) | 1989-12-13 | 1995-06-06 | Lefebvre; Jean-Marie | Filter-catheter and method of manufacturing same |
US5041093A (en) | 1990-01-31 | 1991-08-20 | Boston Scientific Corp. | Catheter with foraminous anchor |
DE69102515T2 (en) | 1990-04-02 | 1994-10-20 | Kanji Inoue | DEVICE FOR CLOSING A SHUTTER OPENING BY MEANS OF A NON-OPERATIONAL METHOD. |
US5078736A (en) | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5234403A (en) | 1990-05-25 | 1993-08-10 | Sumitomo Bakelite Co., Ltd. | Blood collecting apparatus |
US5279546A (en) | 1990-06-27 | 1994-01-18 | Lake Region Manufacturing Company, Inc. | Thrombolysis catheter system |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
CA2048307C (en) | 1990-08-14 | 1998-08-18 | Rolf Gunther | Method and apparatus for filtering blood in a blood vessel of a patient |
US5042707A (en) | 1990-10-16 | 1991-08-27 | Taheri Syde A | Intravascular stapler, and method of operating same |
US5108420A (en) | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
SE467948B (en) | 1991-06-14 | 1992-10-12 | Ams Medinvent Sa | DEVICE FOR TRANSLUMINAL REMOVAL OR IMPLANTATION OF A STENT AND APPARATUS INCLUDING A SOUND DEVICE |
US5458574A (en) | 1994-03-16 | 1995-10-17 | Heartport, Inc. | System for performing a cardiac procedure |
US5735290A (en) | 1993-02-22 | 1998-04-07 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
CA2078530A1 (en) | 1991-09-23 | 1993-03-24 | Jay Erlebacher | Percutaneous arterial puncture seal device and insertion tool therefore |
US5256146A (en) | 1991-10-11 | 1993-10-26 | W. D. Ensminger | Vascular catheterization system with catheter anchoring feature |
DE69229539T2 (en) | 1991-11-05 | 2000-02-17 | Childrens Medical Center | Occlusion device for repairing heart and vascular defects |
CA2082090C (en) | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5176692A (en) | 1991-12-09 | 1993-01-05 | Wilk Peter J | Method and surgical instrument for repairing hernia |
US5258042A (en) | 1991-12-16 | 1993-11-02 | Henry Ford Health System | Intravascular hydrogel implant |
US5626605A (en) | 1991-12-30 | 1997-05-06 | Scimed Life Systems, Inc. | Thrombosis filter |
EP0876793B1 (en) | 1992-01-21 | 2007-12-26 | Regents Of The University Of Minnesota | Septal Defect Closure Device |
US5536412A (en) | 1992-02-06 | 1996-07-16 | Hemocleanse, Inc. | Hemofiltration and plasmafiltration devices and methods |
JPH05245215A (en) * | 1992-03-03 | 1993-09-24 | Terumo Corp | Heart pace maker |
FR2689388B1 (en) | 1992-04-07 | 1999-07-16 | Celsa Lg | PERFECTIONALLY RESORBABLE BLOOD FILTER. |
US5637097A (en) | 1992-04-15 | 1997-06-10 | Yoon; Inbae | Penetrating instrument having an expandable anchoring portion |
US5707362A (en) * | 1992-04-15 | 1998-01-13 | Yoon; Inbae | Penetrating instrument having an expandable anchoring portion for triggering protrusion of a safety member and/or retraction of a penetrating member |
US5766246A (en) | 1992-05-20 | 1998-06-16 | C. R. Bard, Inc. | Implantable prosthesis and method and apparatus for loading and delivering an implantable prothesis |
US5527338A (en) | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
US5469867A (en) | 1992-09-02 | 1995-11-28 | Landec Corporation | Cast-in place thermoplastic channel occluder |
US5368034A (en) | 1992-09-04 | 1994-11-29 | Boston Scientific Corporation | Method and apparatus for thrombolytic therapy |
FR2696092B1 (en) | 1992-09-28 | 1994-12-30 | Lefebvre Jean Marie | Kit for medical use composed of a filter and its device for placement in the vessel. |
DE69315704T3 (en) * | 1992-10-01 | 2002-08-01 | Cardiac Pacemakers Inc | STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES |
US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5443454A (en) | 1992-12-09 | 1995-08-22 | Terumo Kabushiki Kaisha | Catheter for embolectomy |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5284488A (en) | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5314451A (en) | 1993-01-15 | 1994-05-24 | Medtronic, Inc. | Replaceable battery for implantable medical device |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5306234A (en) | 1993-03-23 | 1994-04-26 | Johnson W Dudley | Method for closing an atrial appendage |
US5353784A (en) | 1993-04-02 | 1994-10-11 | The Research Foundation Of Suny | Endoscopic device and method of use |
DE69425966T2 (en) | 1993-04-27 | 2001-03-29 | Haemonetics Corp | Apheresis device |
US5380299A (en) | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
US5527322A (en) | 1993-11-08 | 1996-06-18 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
US5490856A (en) | 1993-12-14 | 1996-02-13 | Untied States Surgical Corporation | Purse string stapler |
US5591196A (en) | 1994-02-10 | 1997-01-07 | Endovascular Systems, Inc. | Method for deployment of radially expandable stents |
US5417708A (en) | 1994-03-09 | 1995-05-23 | Cook Incorporated | Intravascular treatment system and percutaneous release mechanism therefor |
US5634942A (en) | 1994-04-21 | 1997-06-03 | B. Braun Celsa | Assembly comprising a blood filter for temporary or definitive use and a device for implanting it |
US5522836A (en) | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5846261A (en) * | 1994-07-08 | 1998-12-08 | Aga Medical Corp. | Percutaneous catheter directed occlusion devices |
NL9401184A (en) | 1994-07-19 | 1996-03-01 | Cordis Europ | Suction catheter. |
US5433727A (en) | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US5601595A (en) | 1994-10-25 | 1997-02-11 | Scimed Life Systems, Inc. | Remobable thrombus filter |
US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US5643292A (en) | 1995-01-10 | 1997-07-01 | Applied Medical Resources Corporation | Percutaneous suturing device |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
US5614204A (en) | 1995-01-23 | 1997-03-25 | The Regents Of The University Of California | Angiographic vascular occlusion agents and a method for hemostatic occlusion |
US5634936A (en) | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5849005A (en) * | 1995-06-07 | 1998-12-15 | Heartport, Inc. | Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US5681347A (en) | 1995-05-23 | 1997-10-28 | Boston Scientific Corporation | Vena cava filter delivery system |
US5827229A (en) | 1995-05-24 | 1998-10-27 | Boston Scientific Corporation Northwest Technology Center, Inc. | Percutaneous aspiration thrombectomy catheter system |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US5709224A (en) | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5725568A (en) | 1995-06-27 | 1998-03-10 | Scimed Life Systems, Inc. | Method and device for recanalizing and grafting arteries |
US5749883A (en) | 1995-08-30 | 1998-05-12 | Halpern; David Marcos | Medical instrument |
DE69612507T2 (en) | 1995-10-30 | 2001-08-09 | Childrens Medical Center | SELF-CENTERING, SHIELD-LIKE DEVICE FOR CLOSING A SEPTAL DEFECT |
US5769816A (en) | 1995-11-07 | 1998-06-23 | Embol-X, Inc. | Cannula with associated filter |
DE19548658A1 (en) | 1995-12-18 | 1997-06-19 | Biotronik Mess & Therapieg | Extracorporeal control device for an implantable medical device |
US5749894A (en) * | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
NL1002423C2 (en) | 1996-02-22 | 1997-08-25 | Cordis Europ | Temporary filter catheter. |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5858238A (en) * | 1996-03-08 | 1999-01-12 | Baxter Research Medical, Inc. | Salvage of autologous blood via selective membrane/sorption technologies |
US5853422A (en) * | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US5906207A (en) * | 1996-04-04 | 1999-05-25 | Merck & Co., Inc. | Method for simulating heart failure |
AR001590A1 (en) * | 1996-04-10 | 1997-11-26 | Jorge Alberto Baccaro | Abnormal vascular communications occluder device and applicator cartridge of said device |
EP0900051A1 (en) * | 1996-05-08 | 1999-03-10 | Salviac Limited | An occluder device |
US6048331A (en) * | 1996-05-14 | 2000-04-11 | Embol-X, Inc. | Cardioplegia occluder |
US5891178A (en) * | 1996-05-14 | 1999-04-06 | Pacesetter, Inc. | Programmer system and associated methods for rapidly evaluating and programming an implanted cardiac device |
US5830228A (en) | 1996-05-29 | 1998-11-03 | Urosurge, Inc. | Methods and systems for deployment of a detachable balloon at a target site in vivo |
US5662671A (en) * | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5669933A (en) | 1996-07-17 | 1997-09-23 | Nitinol Medical Technologies, Inc. | Removable embolus blood clot filter |
US5823198A (en) | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
US6178351B1 (en) * | 1996-08-19 | 2001-01-23 | The Mower Family Chf Treatment Irrevocable Trust | Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation |
US5941249A (en) * | 1996-09-05 | 1999-08-24 | Maynard; Ronald S. | Distributed activator for a two-dimensional shape memory alloy |
US5876367A (en) * | 1996-12-05 | 1999-03-02 | Embol-X, Inc. | Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries |
US5776097A (en) | 1996-12-19 | 1998-07-07 | University Of California At Los Angeles | Method and device for treating intracranial vascular aneurysms |
US5782860A (en) | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5800457A (en) | 1997-03-05 | 1998-09-01 | Gelbfish; Gary A. | Intravascular filter and associated methodology |
US5851232A (en) * | 1997-03-15 | 1998-12-22 | Lois; William A. | Venous stent |
US5800454A (en) | 1997-03-17 | 1998-09-01 | Sarcos, Inc. | Catheter deliverable coiled wire thromboginic apparatus and method |
US5836913A (en) | 1997-05-02 | 1998-11-17 | Innerdyne, Inc. | Device and method for accessing a body cavity |
US5855597A (en) * | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
US5868708A (en) * | 1997-05-07 | 1999-02-09 | Applied Medical Resources Corporation | Balloon catheter apparatus and method |
US5911734A (en) * | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US5846260A (en) * | 1997-05-08 | 1998-12-08 | Embol-X, Inc. | Cannula with a modular filter for filtering embolic material |
US6059745A (en) * | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US5928192A (en) * | 1997-07-24 | 1999-07-27 | Embol-X, Inc. | Arterial aspiration |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6036720A (en) * | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US5873894A (en) * | 1998-02-17 | 1999-02-23 | Sulzer Intermedics Inc. | Diagnostic test protocol in an implantable medical device |
US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6033420A (en) * | 1998-09-02 | 2000-03-07 | Embol-X, Inc. | Trocar introducer system and methods of use |
US6051014A (en) * | 1998-10-13 | 2000-04-18 | Embol-X, Inc. | Percutaneous filtration catheter for valve repair surgery and methods of use |
US6068621A (en) * | 1998-11-20 | 2000-05-30 | Embol X, Inc. | Articulating cannula |
US6056720A (en) * | 1998-11-24 | 2000-05-02 | Embol-X, Inc. | Occlusion cannula and methods of use |
US6080183A (en) * | 1998-11-24 | 2000-06-27 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
US6024755A (en) * | 1998-12-11 | 2000-02-15 | Embol-X, Inc. | Suture-free clamp and sealing port and methods of use |
US6235044B1 (en) * | 1999-08-04 | 2001-05-22 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue |
US6689150B1 (en) * | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
AU2001285078A1 (en) * | 2000-08-18 | 2002-03-04 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
CA2423360A1 (en) * | 2000-09-21 | 2002-03-28 | Atritech, Inc. | Apparatus for implanting devices in atrial appendages |
WO2002071977A2 (en) * | 2001-03-08 | 2002-09-19 | Atritech, Inc. | Atrial filter implants |
US7011671B2 (en) * | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
US20030023266A1 (en) * | 2001-07-19 | 2003-01-30 | Borillo Thomas E. | Individually customized atrial appendage implant device |
-
2002
- 2002-06-04 WO PCT/US2002/017704 patent/WO2002098282A2/en not_active Application Discontinuation
- 2002-06-04 EP EP02734676A patent/EP1392394A4/en not_active Withdrawn
- 2002-06-04 US US10/163,021 patent/US6941169B2/en not_active Expired - Lifetime
- 2002-06-04 CA CA 2449468 patent/CA2449468A1/en not_active Abandoned
- 2002-06-04 JP JP2003501331A patent/JP2005508208A/en active Pending
-
2004
- 2004-07-23 US US10/897,504 patent/US20050004641A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1392394A2 (en) | 2004-03-03 |
EP1392394A4 (en) | 2005-05-18 |
US20020183823A1 (en) | 2002-12-05 |
US20050004641A1 (en) | 2005-01-06 |
US6941169B2 (en) | 2005-09-06 |
WO2002098282A3 (en) | 2003-05-01 |
WO2002098282A2 (en) | 2002-12-12 |
JP2005508208A (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6941169B2 (en) | Cardiac stimulating apparatus having a blood clot filter and atrial pacer | |
US8938300B2 (en) | Leadless implantable intravascular electrophysiologic device for neurologic/cardiovascular sensing and stimulation | |
JP4430744B2 (en) | Implantable system for patients in need of such treatment with cardiac cardioversion | |
US9974963B2 (en) | Apparatus and method for the detection and treatment of atrial fibrillation | |
US6275730B1 (en) | Method and apparatus for treating cardiac arrythmia | |
US8204605B2 (en) | Multi-site atrial electrostimulation | |
US5978704A (en) | Method and apparatus for treating cardiac arrhythmia | |
US6266563B1 (en) | Method and apparatus for treating cardiac arrhythmia | |
US6442424B1 (en) | Local cardiac motion control using applied electrical signals | |
US20090198294A1 (en) | Baroreflex activation for arrhythmia treatment | |
KR20190060334A (en) | Cerclage atrial implantable cardioverter defibrillators | |
JP2007301401A (en) | Apparatus for detecting and treating ventricular arrhythmia | |
JP2006522650A (en) | Subcutaneous electrode positioning method and system for heart | |
US20220273944A1 (en) | Cardiac stimulation system | |
US8014858B1 (en) | Shockless defibrillation | |
AU2002305822A1 (en) | Cardiac stimulating apparatus having a blood clot filter and atrial pacer | |
EP1216075A1 (en) | Method and apparatus for treating cardiac arrhythmia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |